Researchers at the University of Pennsylvania School of Medicine found that certain changes in DNA sequences can trigger the resulting genome to misfold in such a way that the person is at increased risk for Type 1 diabetes.
https://www.pharmalive.com/wp-content/uploads/2020/02/Research-Roundup-BioSpace-2-21-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2020-02-21 12:38:392020-02-21 13:47:06Research Roundup: Misfolding DNA and Type 1 Diabetes and More